MARKET

CSII

CSII

Cardiovascular
NASDAQ

Real-time Quotes | Nasdaq Last Sale

39.98
+0.14
+0.35%
Opening 15:23 03/05 EST
OPEN
39.98
PREV CLOSE
39.84
HIGH
39.98
LOW
38.50
VOLUME
186.40K
TURNOVER
--
52 WEEK HIGH
48.28
52 WEEK LOW
26.00
MARKET CAP
1.61B
P/E (TTM)
-69.7975
1D
5D
1M
3M
1Y
5Y
Cardiovascular Devices Market Size to accrue $ 74 billion by 2027
Mar 04, 2021 (Market Insight Reports) -- Selbyville, Delaware Market Study Report LLC adds new research on Cardiovascular Devices market, which is a detailed...
Market Insight Reports · 1d ago
ExtraCorporeal Membrane Oxygenation Market Trends, Size, Competitive, Growth Insight, Share, Emerging Technologies, Share, And Forecast To 2026
Mar 04, 2021 (The Expresswire) -- The GlobalExtra Corporeal Membrane Oxygenation Marketto gain from rapid technological advancements taking place in the...
The Express Wire · 1d ago
Cardiovascular Devices Market | 2021 Size, Share, Sales, Demand, Growth, Merger, Trends, Competitive Landscape And Regional Outlook With Global Industry Forecast To 2026
Mar 03, 2021 (The Expresswire) -- The global “Cardiovascular Devices Industry” is prognosticated to reach USD 82.20 billion by 2026 on account of the...
The Express Wire · 2d ago
Ambulatory Device Market Growing Rapidly with Trends, Development, Investment Opportunities, Size, Share, Revenue, Demand and Forecast to 2026
The Express Wire · 2d ago
Global Interventional Cardiology Diagnostic and Therapeutic Devices Market 2020 Key Business Strategies, Technology Innovation and Regional Data Analysis to 2025
Mar 01, 2021 (CDN Newswire via Comtex) -- Global Interventional Cardiology Diagnostic and Therapeutic Devices Market Growth, Trends, and Forecasts 2015-2025...
CDN Newswire · 4d ago
Cardiovascular Devices Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027
Feb 26, 2021 (Market Insight Reports) -- The Global Cardiovascular Devices Market is estimated to value over USD 82.2 billion by 2027 end at a CAGR of over...
Market Insight Reports · 02/26 13:13
Global Cardiovascular Devices Market Size study, by Product Type (Diagnostic and monitoring devices, Surgical Devices), by Application (Coronary Heart Disease, Sudden Cardiac Arrest, Stroke, Cerebrovascular Heart Disease, Others), by End-User (Hospital, Cardiac Diagnostic Centres, Ambulatory Surgical Centres) and Regional Forecasts 2020-2027
Feb 26, 2021 (Heraldkeepers) -- Global Cardiovascular Devices Market is valued at approximately USD 43 billion in 2019 and is anticipated to grow with a...
Heraldkeepers · 02/26 09:24
Global Ambulatory Device Market 2020 Booming Strategies of Top Companies, Progression Status and Business Trends to 2025
Feb 24, 2021 (CDN Newswire via Comtex) -- Global Ambulatory Device Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 is a...
CDN Newswire · 02/24 15:20
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CSII. Analyze the recent business situations of Cardiovascular through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 10 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CSII stock price target is 47.00 with a high estimate of 55.00 and a low estimate of 38.00.
EPS
Institutional Holdings
Institutions: 317
Institutional Holdings: 39.28M
% Owned: 97.72%
Shares Outstanding: 40.19M
TypeInstitutionsShares
Increased
60
3.20M
New
47
-566.59K
Decreased
74
1.98M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+2.65%
Healthcare Equipment & Supplies
+1.99%
Key Executives
Chairman/President/Chief Executive Officer/Director
Scott Ward
Chief Financial Officer
Jeffrey Points
Chief Operating Officer
Rhonda Robb
Chief Human Resource Officer
Stephen Rempe
Chief Compliance Officer
Sandra Sedo
Vice President - Operations
John Hastings
Vice President
David Whitescarver
General Counsel/Secretary
Alexander Rosenstein
Other
Ryan Egeland
Independent Director
Martha Aronson
Independent Director
Edward Brown
Independent Director
William Cohn
Independent Director
Sachin Jain
Independent Director
Augustine Lawlor
Independent Director
Erik Paulsen
Independent Director
Stephen Stenbeck
Independent Director
Kelvin Womack
No Data
About CSII
Cardiovascular Systems, Inc. is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial applications. Its peripheral artery disease (PAD) systems are catheter-based platforms capable of treating a range of plaque types in leg arteries both above and below the knee. Its products include Diamondback 360 Peripheral Orbital Atherectomy System (OAS) (Diamondback 360 Peripheral), the Stealth 360 OAS (Stealth 360), Diamondback 360 Peripheral, Diamondback 360 60cm Peripheral, Diamondback 360 Low Profile Peripheral, Diamondback 360 1.50 Peripheral and Diamondback 360 2.00 Peripheral. The Company's coronary arterial disease (CAD) product, Diamondback 360 Coronary OAS (Coronary OAS), is marketed as a treatment for severely calcified coronary arteries.

Webull offers kinds of Cardiovascular Systems Inc stock information, including NASDAQ:CSII real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CSII stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CSII stock methods without spending real money on the virtual paper trading platform.